Nexalin Technology (NXL) Cash from Operations (2021 - 2026)
Nexalin Technology (NXL) posted Cash from Operations of -$1.8 million for Q2 2026, down 5.17% on a QoQ basis from -$1.7 million in Q1 2026, and down 96.43% year-over-year from -$50.5 million in Q2 2025.
Analysis
Nexalin Technology (NXL) Cash from Operations (2021 - 2026) Analysis & Trends
Nexalin Technology has reported Cash from Operations for 6 years, with the latest figure at -$1.8 million in Q2 2026.
- On a quarterly basis, Cash from Operations fell 96.43% year-over-year to -$1.8 million in Q2 2026; TTM through Jun 2026 was -$6.1 million, a 43.26% decrease from a year earlier, with the FY2025 full-year figure at -$5.0 million, down 25.69% from the prior year.
- Cash from Operations was -$1.8 million for Q2 2026 at Nexalin Technology, down from -$1.7 million in the prior quarter.
- The five-year high for Cash from Operations was -$162272.0 in Q2 2022, with the low at -$1.8 million in Q2 2026.
- Average Cash from Operations over 5 years is -$1.0 million, with a median of -$973864.5 recorded in 2022.
- The sharpest annual moves came in 2023 and 2024: Cash from Operations plunged 546.75% in 2023, then surged 41.94% in 2024.
- Over 5 years, Cash from Operations stood at -$906457.0 in 2022, then decreased by 10.76% to -$1.0 million in 2023, then dropped by 12.99% to -$1.1 million in 2024, then fell by 1.19% to -$1.1 million in 2025, then sank by 56.93% to -$1.8 million in 2026.
- The last three Cash from Operations figures came in at -$1.8 million (Q2 2026), -$1.7 million (Q1 2026), and -$1.1 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Operations (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 179.79 Bn | 174.18 Bn | 7.27 Bn | 2.49 Bn |
| 2 | Intuitive Surgical | 127.69 Bn | 122.47 Bn | 1.96 Bn | 1.06 Bn |
| 3 | Medtronic | 117.23 Bn | 108.41 Bn | 6.34 Bn | 1.79 Bn |
| 4 | Stryker | 103.55 Bn | 100.07 Bn | 4.50 Bn | 1.26 Bn |
| 5 | Boston Scientific | 63.24 Bn | 62.70 Bn | 3.85 Bn | 1.47 Bn |
| 6 | Edwards Lifesciences | 49.97 Bn | 45.72 Bn | 1.35 Bn | 651.90 Mn |
| 7 | Alcon | 32.83 Bn | 31.37 Bn | 1.68 Bn | 510.00 Mn |
| 8 | Dexcom | 32.30 Bn | 30.35 Bn | 830.00 Mn | 269.20 Mn |
| 9 | Steris | 20.73 Bn | 20.25 Bn | 684.20 Mn | 367.10 Mn |
| 10 | Nexalin Technology | 3.44 Mn | 2.44 Mn | 8,897.00 | -1.80 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -1.80 Mn |
| Mar 31, 2026 | -1.71 Mn |
| Dec 31, 2025 | -1.15 Mn |
| Sep 30, 2025 | -1.47 Mn |
| Jun 30, 2025 | -917,165.00 |
| Mar 31, 2025 | -1.43 Mn |
| Dec 31, 2024 | -1.13 Mn |
| Sep 30, 2024 | -800,210.00 |
| Jun 30, 2024 | -1.25 Mn |
| Mar 31, 2024 | -763,289.00 |
| Dec 31, 2023 | -1.00 Mn |
| Sep 30, 2023 | -701,094.00 |
| Jun 30, 2023 | -815,611.00 |
| Mar 31, 2023 | -1.31 Mn |
| Dec 31, 2022 | -906,457.00 |
| Sep 30, 2022 | -943,699.00 |
| Jun 30, 2022 | -162,272.00 |
| Mar 31, 2022 | -203,271.00 |
| Dec 31, 2021 | -409,091.00 |